243 related articles for article (PubMed ID: 16572451)
1. Antimuscarinic antibodies in primary Sjögren's syndrome reversibly inhibit the mechanism of fluid secretion by human submandibular salivary acinar cells.
Dawson LJ; Stanbury J; Venn N; Hasdimir B; Rogers SN; Smith PM
Arthritis Rheum; 2006 Apr; 54(4):1165-73. PubMed ID: 16572451
[TBL] [Abstract][Full Text] [Related]
2. Putative anti-muscarinic antibodies cannot be detected in patients with primary Sjogren's syndrome using conventional immunological approaches.
Dawson LJ; Allison HE; Stanbury J; Fitzgerald D; Smith PM
Rheumatology (Oxford); 2004 Dec; 43(12):1488-95. PubMed ID: 15353609
[TBL] [Abstract][Full Text] [Related]
3. Antibodies raised against the second extracellular loop of the human muscarinic M3 receptor mimic functional autoantibodies in Sjögren's syndrome.
Cavill D; Waterman SA; Gordon TP
Scand J Immunol; 2004 Mar; 59(3):261-6. PubMed ID: 15030576
[TBL] [Abstract][Full Text] [Related]
4. Functional epitope of muscarinic type 3 receptor which interacts with autoantibodies from Sjogren's syndrome patients.
Koo NY; Li J; Hwang SM; Choi SY; Lee SJ; Oh SB; Kim JS; Lee EB; Song YW; Park K
Rheumatology (Oxford); 2008 Jun; 47(6):828-33. PubMed ID: 18400835
[TBL] [Abstract][Full Text] [Related]
5. Passive transfer of Sjogren's syndrome IgG produces the pathophysiology of overactive bladder.
Wang F; Jackson MW; Maughan V; Cavill D; Smith AJ; Waterman SA; Gordon TP
Arthritis Rheum; 2004 Nov; 50(11):3637-45. PubMed ID: 15529387
[TBL] [Abstract][Full Text] [Related]
6. Inhibitory effects of muscarinic receptor autoantibodies on parasympathetic neurotransmission in Sjögren's syndrome.
Waterman SA; Gordon TP; Rischmueller M
Arthritis Rheum; 2000 Jul; 43(7):1647-54. PubMed ID: 10902771
[TBL] [Abstract][Full Text] [Related]
7. Antiidiotypic antibodies neutralize autoantibodies that inhibit cholinergic neurotransmission.
Cavill D; Waterman SA; Gordon TP
Arthritis Rheum; 2003 Dec; 48(12):3597-602. PubMed ID: 14674012
[TBL] [Abstract][Full Text] [Related]
8. Detection of anti-type 3 muscarinic acetylcholine receptor autoantibodies in the sera of Sjögren's syndrome patients by use of a transfected cell line assay.
Gao J; Cha S; Jonsson R; Opalko J; Peck AB
Arthritis Rheum; 2004 Aug; 50(8):2615-21. PubMed ID: 15334476
[TBL] [Abstract][Full Text] [Related]
9. Evidence that anti-muscarinic antibodies in Sjögren's syndrome recognise both M3R and M1R.
Schegg V; Vogel M; Didichenko S; Stadler MB; Beleznay Z; Gadola S; Sengupta C; Stadler BM; Miescher SM
Biologicals; 2008 Jul; 36(4):213-22. PubMed ID: 18249005
[TBL] [Abstract][Full Text] [Related]
10. Effect of Antimuscarinic Autoantibodies in Primary Sjögren's Syndrome.
Kim N; Shin Y; Choi S; Namkoong E; Kim M; Lee J; Song Y; Park K
J Dent Res; 2015 May; 94(5):722-8. PubMed ID: 25784251
[TBL] [Abstract][Full Text] [Related]
11. Muscarinic acetylcholine type-3 receptor desensitization due to chronic exposure to Sjögren's syndrome-associated autoantibodies.
Cha S; Singson E; Cornelius J; Yagna JP; Knot HJ; Peck AB
J Rheumatol; 2006 Feb; 33(2):296-306. PubMed ID: 16465661
[TBL] [Abstract][Full Text] [Related]
12. Autoantibodies in Sjögren's syndrome patients acutely inhibit muscarinic receptor function.
Jin M; Hwang SM; Koo NY; Kim B; Kho HS; Choi SY; Song YW; Park K
Oral Dis; 2012 Mar; 18(2):132-9. PubMed ID: 21899666
[TBL] [Abstract][Full Text] [Related]
13. Cholinergic autoantibodies from primary Sjögren's syndrome modulate submandibular gland Na+/K+-ATPase activity via prostaglandin E2 and cyclic AMP.
Passafaro D; Reina S; Sterin-Borda L; Borda E
Eur J Oral Sci; 2010 Apr; 118(2):131-8. PubMed ID: 20487001
[TBL] [Abstract][Full Text] [Related]
14. Functional role of M3 muscarinic acetylcholine receptor (M3R) reactive T cells and anti-M3R autoantibodies in patients with Sjögren's syndrome.
Sumida T; Tsuboi H; Iizuka M; Nakamura Y; Matsumoto I
Autoimmun Rev; 2010 Jul; 9(9):615-7. PubMed ID: 20462524
[TBL] [Abstract][Full Text] [Related]
15. Neutralization of muscarinic receptor autoantibodies by intravenous immunoglobulin in Sjögren syndrome.
Smith AJ; Jackson MW; Wang F; Cavill D; Rischmueller M; Gordon TP
Hum Immunol; 2005 Apr; 66(4):411-6. PubMed ID: 15866705
[TBL] [Abstract][Full Text] [Related]
16. The role of M3 muscarinic acetylcholine receptor reactive T cells in Sjögren's syndrome: a critical review.
Sumida T; Tsuboi H; Iizuka M; Hirota T; Asashima H; Matsumoto I
J Autoimmun; 2014 Jun; 51():44-50. PubMed ID: 24397962
[TBL] [Abstract][Full Text] [Related]
17. Effect of anti-muscarinic autoantibodies on leukocyte function in Sjögren's syndrome.
Namkoong E; Lee SW; Kim N; Choi Y; Park K
Mol Immunol; 2017 Oct; 90():136-142. PubMed ID: 28750255
[TBL] [Abstract][Full Text] [Related]
18. [Analysis of epitopes and function of anti-M3 muscarinic acetylcholine receptor antibodies in patients with Sjögren's syndrome].
Tsuboi H; Matsuo N; Iizuka M; Nakamura Y; Matsumoto I; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2010; 33(4):222-8. PubMed ID: 20818151
[TBL] [Abstract][Full Text] [Related]
19. [Anti-M3 muscarinic acetylcholine receptor antibodies and Sjögren's syndrome].
Tsuboi H; Iizuka M; Asashima H; Sumida T
Nihon Rinsho Meneki Gakkai Kaishi; 2013; 36(2):77-85. PubMed ID: 23629427
[TBL] [Abstract][Full Text] [Related]
20. Sjögren's syndrome in the NOD mouse model is an interleukin-4 time-dependent, antibody isotype-specific autoimmune disease.
Gao J; Killedar S; Cornelius JG; Nguyen C; Cha S; Peck AB
J Autoimmun; 2006 Mar; 26(2):90-103. PubMed ID: 16413168
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
